BioPharma Credit PLC Notice of Half Year Results (4919W)
August 18 2020 - 10:25AM
UK Regulatory
TIDMBPCR
RNS Number : 4919W
BioPharma Credit PLC
18 August 2020
18 August 2020
BIOPHARMA CREDIT PLC
(The "Company")
NOTICE OF HALF YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences
debt investor, will announce its Half Year Results for the period
ended 30 June 2020 on Wednesday 16 September 2020.
A management presentation for analysts will be delivered at 2pm
BST on the day of the results through a conference call
facility.
To request conference call details, RSVP to
biopharmacredit@buchanan.uk.com .
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORGPUPGRUPUGCR
(END) Dow Jones Newswires
August 18, 2020 10:25 ET (14:25 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024